http://dermatologytimes.modernmedicine.com/dermatologytimes The Leading Newsmagazine for Dermatologists. Dermatology Times is a newsmagazine devoted to reporting timely information on the latest trends in the dermatology market. As such, it covers new procedures; advances in therapy, new products and drugs, the latest information presented at meetings, interviews with leaders in practice, academics and research. 2008-07-25T13:07:17Z http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/MacroChem-announces-phase-2-data-for-EcoNail-in-tr/ArticleStandard/Article/detail/531609?ref=25 New York — MacroChem Corporation announces results of a phase 2 clinical trial of EcoNail,a topical antifungal for the treatment of onychomychosis, according to Earthtimes.org. 2008-07-24T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/302008/531609null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/NovaBay-anounces-details-of-dermatology-program/ArticleStandard/Article/detail/530891?ref=25 Emeryville, Calif. — NovaBay Parmaceuticals announces it has successfully developed several formulations of Agonocide compounds for use in dermatology. 2008-07-21T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/302008/530891null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Web+Exclusive/Surviving-melanoma-California-woman-marks-five-yea/ArticleStandard/Article/detail/530400?ref=25 Napa, Calif. — Stage 4 melanoma survivor Kari Worth, 41, marked her five-year triumph over the disease with a five-day, 76-mile walk, ending with a trip across San Francisco’s Golden Gate Bridge to deliver a bottle of champagne to her oncologist. 2008-07-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530400null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Galderma-approved-for-DifferinR-Gel-01-percent-in-/ArticleStandard/Article/detail/530378?ref=25 Lausanne, Switzerland — Galderma Pharma S.A. announced that Japan’s Health Labor and Welfare has approved Differin(R) Gel 0.1 percent (adapalene). 2008-07-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530378null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/York-Pharma-raises-pound28-million-to-fund-acquisi/ArticleStandard/Article/detail/530080?ref=25 Milton Keynes, England — York Pharma has raised £28 million to fund a multi-million pound acquisition of Flammazine and Flammacerium from Solvay, according to BusinessWeekly.co.uk. 2008-07-16T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530080null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Melanoma-rates-rise-in-younger-women/ArticleStandard/Article/detail/529372?ref=25 National report — The rate of melanoma cases in younger women has increased 50 percent since 1980, but did not increase in younger men, according to a study published in the Journal of Investigative Dermatology. 2008-07-14T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/529372null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Dermatology-Foundation-seeks-award-nominees/ArticleStandard/Article/detail/529268?ref=25 Evanston, Ill. —The Dermatology Foundation is accepting nominations for the 2008 Clark W. Finnerud and 2008 Practitioner of the Year awards. 2008-07-11T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/529268null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/UV-light-therapy-as-beneficial-for-darker-skin-as-/ArticleStandard/Article/detail/528610?ref=25 Dallas — An analysis of more than 100 patients shows that darker-skinned patients benefit from light therapy to treat morphea and related diseases as much as lighter-skinned patients, according to ScienceDaily. 2008-07-09T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528610null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Thermage-to-buy-Reliant-for-875-million-plus-debt/ArticleStandard/Article/detail/528346?ref=25 New York — Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press. 2008-07-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528346null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Etanercept-demonstrates-therapeutic-effect-on-kelo/ArticleStandard/Article/detail/528302?ref=25 National report — A study shows that intralesional etanercept may provide an effective treatment for keloids, according to TherapeuticsDaily. 2008-07-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528302null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/FDA-approves-Evolence-for-treating-facial-wrinkles/ArticleStandard/Article/detail/528253?ref=25 National report — The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, according to maker Johnson and Johnson. 2008-07-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528253null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/The-Skin-Cancer-Foundation-call-for-submissions-fo/ArticleStandard/Article/detail/527631?ref=25 National report — The Skin Cancer Foundation is accepting applications for support of pilot research projects related to skin cancer, according to a press release. 2008-07-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527631null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/One-million-new-skin-cancer-cases-expected-in-US-t/ArticleStandard/Article/detail/527636?ref=25 Schaumburg, Ill. — Approximately one million new skin cancer cases will be diagnosed in the United States in 2008, according the the American Academy of Dermatology. 2008-07-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527636null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/Military-gains-Regenerative-medicine-project-will-/ArticleStandard/Article/detail/528087?ref=25 The Department of Defense (DOD) has awarded a multimillion-dollar research grant to develop new therapies for wounded soldiers, which may hasten the pace at which unique, innovative burn and wound healing and cosmetic procedures become commonly used in treating civilians. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528087null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/Healthcare-reform-Pollsters-say-Americans-want-cha/ArticleStandard/Article/detail/528089?ref=25 The number of Americans who want "radical change" in the U.S. healthcare system has reached 36 percent, focusing intense national attention on the issue, says Republican pollster Bill McInturff, who has tracked the question since 1992. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528089null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Other/Misnomer-Tropical-Dermatology/ArticleStandard/Article/detail/528090?ref=25 Dermatologists must look outside their regional communities for the source of unique symptoms. A history of tropical travel isn't always a precursor to tropical disease. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528090null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Other/After-the-burn-Encouraging-results-from-autologous/ArticleStandard/Article/detail/528091?ref=25 Autologous fibroblast therapy (Isolagen, Isolagen, Inc.) has been used to achieve functional and cosmetic improvements in patients with acute and chronic burn injuries involving the face, neck, hands, and chest. The treatment was safe and well-tolerated and associated with high patient satisfaction. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528091null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis/PHOENIX-study-evaluates-the-safety-efficacy-of-ust/ArticleStandard/Article/detail/528096?ref=25 PHOENIX 1 is a phase 3 study evaluating the efficacy and safety of ustekinumab (Centocor), a fully human interleukin-12/23p40 monoclonal antibody, in patients with moderate-to-severe chronic plaque psoriasis. The study randomized 766 patients to receive ustekinumab 45 mg, ustekinumab 90 mg or placebo at weeks zero and four. Data from 52 weeks and 76 weeks show high proportions of patients are maintaining PASI 75 responses with maintenance injections every 12 weeks. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528096null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Pediatric+Dermatology/Vascular-anomalies-Clinicians-must-treat-underlyin/ArticleStandard/Article/detail/528102?ref=25 When children present with port wine stains, clinicians should consider serious conditions and underlying disease. Vascular anomalies can be classified into two major groups: vascular tumors, which infantile hemangiomas are the most frequent, and vascular malformations. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528102null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Ethnic+Skin/Hispanic-skin-conditions-Understanding-diseases-cu/ArticleStandard/Article/detail/528103?ref=25 Hispanics are more prone to hyperpigmentation than their Caucasian counterparts. Another condition that is more common in Hispanics is melasma, which occurs with significant frequency in pregnant women. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528103null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Ethnic+Skin/Treating-Asian-skin-Fast-growing-population-requir/ArticleStandard/Article/detail/528106?ref=25 Although Asians are the fastest-growing population group in the United States, most dermatologists are not familiar with differences in the skin of Asians as compared to Caucasian patients. Signs of aging are different, and more delicate treatment is needed for sensitive Asian skin. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528106null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Actinic-keratoses-What-are-the-risks-if-left-untre/ArticleStandard/Article/detail/528125?ref=25 Many physicians believe that if left untreated, actinic keratoses will become a grave danger to the patient. According to a French dermatologist, however, actinic keratosis usually poses no threat to the life of the patient, and the immediate treatment of these lesions is not mandatory, provided that the AKs that evolve into more advanced tumors are detected and treated, and that patients are not immunosuppressed. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528125null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/NRS-survey-suggests-links-between-rosacea-and-gene/ArticleStandard/Article/detail/526025?ref=25 Barrington, Ill. — Results of a recently released survey indicate that rosacea may be genetic, the National Rosacea Society (NRS) reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526025null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/Study-recommends-daily-counts-to-assess-degree-of-/ArticleStandard/Article/detail/526021?ref=25 Houston — A new study shows that people worried about hair loss can count on counting as a way to find out if their concerns are justified, HealthDay News reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526021null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Legal+%26+Legislative/Legal-Using-patient-videos-for-teaching-requires-i/ArticleStandard/Article/detail/528084?ref=25 Dr. Photo has lectured at numerous American Academy of Dermatology meetings. His lectures are well-attended and receive the highest attendee rankings. His PowerPoint presentations are always noted for their exceptional clarity. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528084null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Preventing-photogenotoxicity-Stable-broad-spectrum/ArticleStandard/Article/detail/528092?ref=25 In vitro studies evaluated the transmission profiles and photostability of three commercially available sunscreens, as well as their activity for protecting against UV-induced cytotoxicity and genotoxicity. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528092null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis/Promising-outlook-Study-shows-efalizumab-provides-/ArticleStandard/Article/detail/528095?ref=25 The results of a three-year study with efalizumab show that patients with moderate-to-severe psoriasis are able to maintain high PASI scores, reflecting long-term hope for disease-free intervals. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528095null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Fillers/A-wrinkle-in-time-Growing-list-of-filler-options-a/ArticleStandard/Article/detail/528127?ref=25 As applications for botulinum toxin treatments, fillers, lasers and light sources expand, an expert cautions against overly aggressive treatment. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528127null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Lasers/Low-level-light-therapy-Despite-controversy-techno/ArticleStandard/Article/detail/527988?ref=25 Low-level light therapy has been shown again to be beneficial in wound healing. According to one expert, physicians should embrace this technology more open-heartedly and try to bring this very effective therapy more into the mainstream. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527988null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Lasers/Resurfacing-safety-Study-indicates-plasma-safer-th/ArticleStandard/Article/detail/528284?ref=25 A new study quantifies the significant improvements in safety that plasma skin resurfacing offers versus ablative CO2 laser resurfacing, one of its authors says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528284null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/The-government-and-dermatologic-surgery-Reimbursem/ArticleStandard/Article/detail/528128?ref=25 Government reimbursements for dermatologic procedures are shrinking, while the number of cases of skin cancer continue to rise. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528128null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Evolving-melanoma-treatments-Field-is-work-in-prog/ArticleStandard/Article/detail/528118?ref=25 Despite years of clinical trials involving cytotoxics, DNA-damaging agents, immunomodulatory therapies and other interventions, the natural history of melanoma has changed very little. However, new treatments offer hope. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528118null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Dramatic-response-Experimental-agent-inhibits-aber/ArticleStandard/Article/detail/528122?ref=25 Advanced basal cell carcinoma responded dramatically to an experimental agent that inhibits the aberrant Hedgehog signaling pathway, according to a recent study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528122null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/And-dermoscopy-for-all-Three-point-checklist-helps/ArticleStandard/Article/detail/528124?ref=25 A three-point checklist applied in dermoscopy could significantly assist non-experts of dermoscopy to accurately diagnose suspicious skin lesions, according to a recent study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528124null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Letters+to+the+Editor/Letter-to-the-editor-Physician-offers-alternatives/ArticleStandard/Article/detail/528083?ref=25 Dr. Norman Levine (Commentary, May 2008) should be applauded for his bravery in publicly questioning the relative value of skin cancer screening events. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528083null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Ethnic+Skin/Facial-hyperpigmentation-Skin-of-color-responds-we/ArticleStandard/Article/detail/528107?ref=25 Two products developed for treating facial hyperpigmentation in women with skin of color were compared head-to-head in a 12-week, randomized, double-blind clinical trial. Similar improvements were achieved at all follow-ups in multiple assessments among women using a hydroquinone-based product and those randomized to apply a cream containing vitamins A, C and E. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528107null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Q-amp-A-Cosmetic-use-of-caviar-the-term-hypoallerg/ArticleStandard/Article/detail/528109?ref=25 The popularity of microdermabrasion procedures in the physician's office and in spa settings has led the skincare industry to develop its own version of the technique. Most of the home microdermabrasion devices do not physically remove skin scales as aggressively as the professional devices — for safety reasons — but produce a consumer-perceivable, tactile, skin-smoothing effect. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528109null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Improving-photoaging-symptoms-Sunscreen-moisturizi/ArticleStandard/Article/detail/528112?ref=25 A new, photostable UVA/UVB filter has demonstrated the ability to improve the appearance of a variety of photoaging symptoms, according to a recent study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528112null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Judgment-call-Difficult-Squamous-Cell-Carcinomas-r/ArticleStandard/Article/detail/528126?ref=25 Treating patients with multiple SCCs requires clearing dermal disease first, then addressing field in situ disease topically; physicians are frequently required to make judgment calls, an expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528126null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/Volunteers-tee-off-on-skin-cancer-with-free-exams-/ArticleStandard/Article/detail/526026?ref=25 Havre de Grace, Md. — Skin cancer screenings and sun safety outreach were offered at one of the major tournaments in the women’s professional golf tour, SunHerald.com reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526026null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Research-shows-need-for-regular-ophthalmic-screeni/ArticleStandard/Article/detail/526024?ref=25 New York — Patients with metastatic cutaneous melanoma should be periodically given an ophthalmic examination to screen for metastasis to the eye, lids and orbit, according to a study reported by HealthDay News. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526024null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/California-company-completes-phase-1-study-of-lsqu/ArticleStandard/Article/detail/526028?ref=25 San Mateo, Calif. — Pain Therapeutics recently announced the completion of its first clinical study utilizing what it calls a novel melanoma treatment, TradingMarkets.com reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526028null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Lasers/Emerging-laser-technologies-Latest-devices-sure-to/ArticleStandard/Article/detail/527986?ref=25 An expert discusses emerging laser technology for at-home hair removal, fat transfer or facelifts, much of which is still being researched or in early marketing stages. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527986null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Office+Management/Opinions-Growing-medspa-industry-shrinking-economy/ArticleStandard/Article/detail/528082?ref=25 Over the past 10 to 15 years, there has been a boom in the phenomenon commonly known as "medspas" — an outgrowth of the purely Aesthetic day spa, combining herbal wraps and massages with medical or near-medical therapies, such as microdermabrasion and chemical peels, and progressing into lasers, fillers and Botox treatments. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528082null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/Strategies-for-success-Dermatology-residents-say-p/ArticleStandard/Article/detail/528085?ref=25 The path to a dermatology residency begins early, and, increasingly, includes a year off from medical school for research, residents say. Prospective dermatology residents also are advised to be flexible, earn strong clinical recommendations and consider an "audition" rotation. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528085null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Other/Tinea-capitis-Fungal-isolates-highly-susceptible-t/ArticleStandard/Article/detail/528098?ref=25 Fungal isolates from patients with tinea capitis participating in international clinical trials were tested for in vitro susceptibility to terbinafine. The results showed terbinafine had potent activity against all 301 dermatophytes tested. There was no difference in MIC values comparing U.S. and non-U.S. isolates of the same organism. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528098null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Other/Southern-tick-associated-rash-illness-reports-beco/ArticleStandard/Article/detail/528100?ref=25 Southern tick-associated rash illness (STARI) presents similar to Lyme disease with an enlarging, erythematous, annular patch or plaque, but may differ from Lyme disease in several respects. Clinical features of STARI and considerations for the diagnosis and treatment of Lyme disease are discussed. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528100null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Ethnic+Skin/Less-cancer-higher-mortality-Unique-symptoms-in-bl/ArticleStandard/Article/detail/528104?ref=25 Unique clinical presentations in skin cancers among ethnic people can confuse physicians and perpetuate the problem of later diagnoses and higher mortality rates in darker-skinned individuals. Physicians should be particularly careful in checking feet and hands for possible signs of skin cancer, and use care not to confuse signs with those of other conditions. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528104null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Laser-eye-safety-How-to-keep-you-your-staff-and-yo/ArticleStandard/Article/detail/528111?ref=25 With the continued introduction of laser devices with unique delivery systems and wavelengths, the issue of eye safety is becoming increasingly complicated. Consistent and competent eye safety procedures for operator, patient, observer and assistant are crucial to a safe and successful laser practice. Despite our increased knowledge of lasers and laser safety, eye injuries in the workplace are still a common problem, with many injuries going undetected well after the incident. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528111null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Brushing-away-wrinkles-Sonic-care-improves-appeara/ArticleStandard/Article/detail/528116?ref=25 A sonic skincare brush has demonstrated effectiveness at increasing absorption of topical agents and improving the appearance of photoaged skin, one of the product's developers says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528116/89_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Improving-photodamage-Clinical-study-corroborates-/ArticleStandard/Article/detail/528114?ref=25 The efficacy and safety of a cosmeceutical cream containing conjugated linoleic acid (CLA) for improving the appearance of facial photodamage skin was investigated in a 16-week, randomized, double-blind, split-face study of 25 women. Assessments of changes in periorbital skin showed statistically significant differences favoring use of the CLA-containing cream. No skin irritation was noted throughout the study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528114/84-85_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Detecting-melanoma-Digital-dermoscopy-total-body-p/ArticleStandard/Article/detail/528123?ref=25 Diagnostics techniques such as dermoscopy, total body photography and digital dermoscopy can assist the dermatologist in diagnosing troublesome nevi and catching early melanomas more frequently. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528123null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Laser-Guide/ArticleStandard/Article/detail/527989?ref=25 2008 DT Laser & Light Technology Guide 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527989null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/How-sweet-it-is-Honey-shows-promise-in-eradicating/ArticleStandard/Article/detail/528088?ref=25 Medical-grade honey kills antibiotic-resistant bacteria — including Staphylococcus — in the test tube, and eradicates colonies on the skin of healthy volunteers, Dutch researchers report. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528088null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis/New-hope-Biologics-target-IL-12-and--23-in-treatin/ArticleStandard/Article/detail/528097?ref=25 Two biologic agents under investigation show promise in the treatment of psoriasis by targeting IL-12 and -23, says an expert. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528097null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Graft-coding-Expert-reviews-AMAs-current-terminolo/ArticleStandard/Article/detail/528129?ref=25 Current Procedural Terminology codes were significantly changed in 2007 to clarify previous confusion, and physicians must understand the changes in order to submit the correct billing and, ultimately, to be reimbursed, one expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528129null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Broad-spectrum-knowledge-Understanding-sunscreen-e/ArticleStandard/Article/detail/528093?ref=25 The proposed new rules for sunscreens issued by the FDA have focused attention on understanding the different methods available for assessing UVA protection. Considering the limitations of various tests and real-world product use patterns, it is important that a sunscreen demonstrate both high levels of in vivo and in vitro protection against UVA as well as a high SPF level. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528093null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Standing-watch-Sentinel-lymph-node-biopsy-demonstr/ArticleStandard/Article/detail/528120?ref=25 Emerging data indicate the sentinel lymph node biopsy may not only stage the regional lymph nodes of patients with melanoma and have prognostic value, but may be therapeutic as well. Data from the Multicenter Selective Lymphadenectomy Trial (MSLT-1), an investigation consisting of patients with clinically node-negative melanoma, demonstrated a survival advantage in a subset of patients who had a positive node. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528120null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Chemo-teamed-with-ADH-1-found-effective-in-treatin/ArticleStandard/Article/detail/526022?ref=25 Durham, N.C. — A new study suggests that chemotherapy is more effective on melanoma tumors if a protein commonly found in the growth can first be disabled, HealthDay News reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526022null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Basal-cell-carcinomas-Doctors-look-to-nonsurgical-/ArticleStandard/Article/detail/528119?ref=25 Dermatologists have been growing increasingly comfortable and confident with nonsurgical treatments for basal cell carcinomas, according to one expert. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528119null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis/Express-treatment-Infliximab-maintenance-treatment/ArticleStandard/Article/detail/528094?ref=25 The phase 3 EXPRESS II trial data show infliximab (Remicade, Centocor) maintenance treatment with regularly administered infusions is associated with better psoriasis control and fewer infusion reactions than intermittent, as-needed dosing. A composite analysis of infliximab phase 2 and 3 study data shows consistently dramatic improvements across all four body regions evaluated in the studies. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528094null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Antioxidant-anti-aging-cream-passes-multifaceted-e/ArticleStandard/Article/detail/528113?ref=25 A new, antioxidant-rich skin cream has demonstrated efficacy regarding a range of anti-aging parameters, researchers say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528113null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Obagi-reports-positive-results-in-testing-of-acne-/ArticleStandard/Article/detail/526027?ref=25 Long Beach, Calif. — Obagi Medical Products, based here, has released results of a study on its solubilized 5 percent benzoyl peroxide (BPO) gel treatment for acne, Business Wire reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526027null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Making-the-grade-Lip-volume-scale-shows-reliabilit/ArticleStandard/Article/detail/528115?ref=25 The first validated scale for grading lip volume has proven its accuracy and robustness in a variety of tests, according to one of the scale's developers. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528115null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Filler-success-Technique-consultation-trump-produc/ArticleStandard/Article/detail/528117?ref=25 With the array of filler options now available, successful treatment requires knowing what patients want when determining the most effective product for the job, an expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528117null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Finance/Going-offshore-Is-international-asset-planning-rig/ArticleStandard/Article/detail/528134?ref=25 Over the last decade, an increasing number of doctors have looked at international approaches to their wealth planning. There are numerous pitfalls for using international planning that can catch naïve doctors. Learn what to do — and what to avoid — in international planning, and about specific tools top attorneys use in their international planning. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528134null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Legal+%26+Legislative/Commentary-Politics-and-patient-safety-lawmakers-w/ArticleStandard/Article/detail/528080?ref=25 I recently read a short newspaper story (USA Today, May 27, 2008) from California, where it was reported that "two lawmakers want greater protection for cosmetic surgery patients." 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528080null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/Brain-drain-Dermatologists-shunning-leaving-academ/ArticleStandard/Article/detail/528086?ref=25 While schools known for academic dermatology produce and retain a relatively high proportion of academic dermatologists, the career path on the whole suffers from low interest among recent graduates — and high attrition rates over time, experts say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528086null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Rosacea/Rosacea-treatments-Delayed-release-doxycycline-40-/ArticleStandard/Article/detail/528099?ref=25 Study shows comparable efficacy and onset of therapeutic effect with doxycycline 40 mg (delayed release) once daily or doxycycline 100 mg once daily for treatment of rosacea, with some differences in adverse effects. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528099null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Perceived-age-Eyes-skin-tone-give-away-years/ArticleStandard/Article/detail/528108?ref=25 A study showing that the periocular area and skin color uniformity are key drivers of perceived age suggests that aesthetic physicians and skincare companies should target these attributes, authors say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528108null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Finance/Uncertain-times-Protecting-your-assets-in-a-fickle/ArticleStandard/Article/detail/528133?ref=25 As I write this, millions of Americans are straining under the pressures of a fickle, unpredictable economy. Tens of thousands of workers have lost their jobs in recent months, savers are struggling to make sense of the lowest interest rates that some have ever seen, and the stock market has given new meaning to the word "volatility." All of this while gasoline and food prices surge to record highs. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528133null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/DermTech-names-Australian-skin-cancer-authority-to/ArticleStandard/Article/detail/526029?ref=25 La Jolla, Calif. — DermTech, a biotech company that develops molecular diagnostics for the early detection of melanoma and other diseases, has named skin cancer expert Scott Menzies, M.B., B.S., Ph.D., to its Melanoma Advisory Board, PRNewswire reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526029null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/FDA-reviews-tumor-necrosis-factor-blockers-Scrutin/ArticleStandard/Article/detail/528079?ref=25 The ongoing Food and Drug Administration (FDA) review of TNF-blocking biologic drugs is unlikely to have much impact on dermatologists' use of these drugs, physicians say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528079null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Autologous-fibroblast-therapy-Pivotal-trials-drawi/ArticleStandard/Article/detail/528110?ref=25 Two identical pivotal trials evaluating the safety and efficacy of autologous fibroblast therapy (Isolagen Technologies) compared with placebo are almost finished. Special attention was paid in protocol design so there would be consistency across the studies in cell harvesting and injection technique, as well as in outcomes assessments. The treatment protocol, which varies from previous studies, aims to optimize the treatment effect. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528110null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Irritant/Hand-dermatitis-Patch-testing-could-play-predictiv/ArticleStandard/Article/detail/528101?ref=25 Patch-testing might be a helpful tool in determining individuals who may be at risk for developing irritant hand dermatitis, according to a recent study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528101null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Ethnic+Skin/Black-is-beautiful-Looking-at-skin-concerns-of-pat/ArticleStandard/Article/detail/528105?ref=25 When treating patients of color, dermatologists need to be aware of unique concerns and make an earlier diagnosis of serious problems, such as cancer, an expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528105/66_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Mohs-goes-South-Micrographic-surgery-gaining-footh/ArticleStandard/Article/detail/528130?ref=25 The Mohs surgeon who introduced the technique in Brazil shares practical tips for successful Mohs surgery. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528130null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Office+Management/Worth-a-thousand-words-Pictures-can-speak-volumes-/ArticleStandard/Article/detail/528131?ref=25 Clinical photography in dermatology can be an invaluable tool, if used properly. Following some basic guidelines can take the guesswork out, lend credibility and present a much more accurate picture. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528131null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Office+Management/Knowing-the-warning-signs-Recognize-key-performanc/ArticleStandard/Article/detail/528132?ref=25 Maybe you've been blindsided by a "crisis" in your business office, and only then regretted not spending time to detect the early warning signs. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528132null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Lasers/Laser-amp-Light-complications-Cautious-treatment-c/ArticleStandard/Article/detail/527987?ref=25 Avoiding laser and light complications requires practicing universal safety precautions, because complications can happen even with the most experienced equipment operators, an expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527987null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Skin+Cancer/Nonmelanoma-skin-cancers-Alarming-incidence-rates-/ArticleStandard/Article/detail/528121?ref=25 Incidence rates of nonmelanoma skin cancers may be higher than estimated. Ultraviolet light-induced skin cancer is an occupational disease, according to one expert. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528121null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Physician%27s+Profile/Physicians-profile-Chicago-dermatologist-focuses-c/ArticleStandard/Article/detail/528135?ref=25 Mario E. LaCouture, M.D., discovered during his residency that the role of dermatology in cancer patients' lives was much greater than just treating skin cancers. He would watch as breast, lung, colon and other cancer patients would complain about the damage that anticancer treatments — especially the new biologics — were doing to their skin. Patients in phase 1 and 2 clinical trials, who had exhausted their treatment options, were having to forgo life-prolonging treatment because of life-altering cutaneous effects, including itching so severe that they could not function or sleep. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528135/138_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/News/Residency-rivalries-Demand-for-dermatology-slots-u/ArticleStandard/Article/detail/528078?ref=25 With competition for dermatology residency slots keener than ever, some program directors worry that the application process weeds out potentially excellent dermatologists who didn't finish at the top of their classes. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528078null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Legal+%26+Legislative/Legislative-Doctors-await-fate-of-Medicare-cut-sma/ArticleStandard/Article/detail/528081?ref=25 The other day, I was visiting with my doctor following my annual checkup, and I asked him about the key concerns that he faces in his regional, three-physician practice in the Baltimore, Md., suburbs. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528081null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/AAD-research-shows-athletes-susceptible-to-MRSA/ArticleStandard/Article/detail/526363?ref=25 Schaumburg, Ill — Methicillin-resistant Staphylococcus aureus is becoming increasingly common in people participating in sports, particularly high school and college athletes, according to a study published in the Journal of the American Academy of Dermatology. 2008-06-26T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526363null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/NICE-recommends-adalimumab-as-treatment-for-plaque/ArticleStandard/Article/detail/526368?ref=25 National report — The National Institute for Health and Clinical Excellence (NICE) is recommending adalimumab as a treatment for adults with plaque psoriasis, redOrbit reports. 2008-06-26T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526368null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/DT-July-E-news-art/ArticleStandard/Article/detail/526081?ref=25 2008-06-25T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526081null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/New-drug-trial-for-Bullous-Pemphigoid/ArticleStandard/Article/detail/525535?ref=25 Nottingham, England — A five-year 'BLISTER' study is being coordinated by two universities, as they are seeking 250 bullous pemphigoid sufferers to participate in a randomized trial, according to Media-Newswire. 2008-06-23T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/525535null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Stiefel-Laboratories-to-acquire-Barrier-Therapeuti/ArticleStandard/Article/detail/525532?ref=25 Coral Gables, Fla. — Stiefel Laboratories has announced it has signed a definitive merger agreement to acquire Barrier Therapeutics, according to PRNewswire. 2008-06-23T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/525532null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/AAD-MLB-MLBPA-team-up-to-educate-players-and-fans-/ArticleStandard/Article/detail/525292?ref=25 Schaumburg, Ill. — The American Academy of Dermatology (AAD), Major League Baseball Association (MLB) and Major League Baseball Players Association (MLBPA) have teamed up to educate players and fans about the risk of skin cancer, according to PRNewswire. 2008-06-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252008/525292null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Dermatology-Nurses-Association-to-launch-its-own-j/ArticleStandard/Article/detail/524942?ref=25 Mt. Laurel, N.J. — The Dermatology Nurses' Association (DNA) is teaming up with international publisher Lippincott, Williams and Wilkins'(LWW) to launch its own journal that will be available in its entirety online, according PR Newswire. 2008-06-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252008/524942null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/FDA-panel-backs-ustekinumab-for-treating-psoriasis/ArticleStandard/Article/detail/524674?ref=25 Silver Springs, Md. — An Food and Drug Administration (FDA) panel ruled Johnson & Johnson's experimental drug, ustekinumab, should be approved for treating moderate to severe psoriasis in adults, Reuters reports. 2008-06-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252008/524674null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Study-offers-insight-into-future-baldness/ArticleStandard/Article/detail/524439?ref=25 National report — A study published in the June issue of the Archives of Dermatology demonstrate a hair-count method to determine if you're balding, according to HealthDay News. 2008-06-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252008/524439null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Medicis-expands-with-purchase-of-LipoSonix/ArticleStandard/Article/detail/524432?ref=25 Scottsdale, Ariz. — Medicis' purchase of LipoSonix, an ultrasound technology used to target fat cells, will launch the company into the international marketplace and the body-contouring business, the East Valley Scottsdale Tribune reports. 2008-06-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252008/524432null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Atralin-gel-enhances-tretinoins-proven-effectivene/ArticleStandard/Article/detail/524501?ref=25 Miami — The formulation of Atralin Gel 5 percent acts to enhance the performance of the active ingredient,tretinoin, against the papules and pustules of acne, according to an expert. 2008-06-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252008/524501null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/New-line-of-attack-Immune-system-induces-tumor-dor/ArticleStandard/Article/detail/523725?ref=25 Tubingen, Germany — Researchers from Tubingen University have discovered that immune response can prevent tumor growth without killing tumor cells, according to ecancermedicalscience. 2008-06-13T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242008/523725null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Allergan-set-to-unveil-eyelash-growing-product/ArticleStandard/Article/detail/523452?ref=25 Irvine, Calif. — Allergan is planning to file a New Drug Application to the FDA by end of the third quarter of 2008 for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth, according to a press release. 2008-06-12T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242008/523452null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Skinvisible-appoints-new-vice-president-of-busines/ArticleStandard/Article/detail/523169?ref=25 Las Vegas — Skinvisible, the developer of Invisicare, announces Doreen McMorran will serve as vice president of business development and marketing for the company, Earthtimes.org reports. 2008-06-11T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242008/523169null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Pediatric-psoriasis-linked-to-genetics/ArticleStandard/Article/detail/522634?ref=25 Toronto — Psoriasis presentation in childhood marks a stronger genetic component than when the disease onset occurs in adulthook, according to an expert. 2008-06-09T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242008/522634null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Allergan-buys-Aczone-Gel-5-percent-from-QLT-USA/ArticleStandard/Article/detail/522630?ref=25 Irvine, Calif. — Allergan has announced it has entered an agreement with QLT USA to purchase Aczone (dapsone) Gel 5 percent, according to socalTech.com. 2008-06-09T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242008/522630null HTML